In a recent Cell Reports article, a team led by investigators at the San Raffaele Institute in Milan, Italy, shows that endogenous microRNAs, like miR-511-3p, "may operate to establish thresholds for inflammatory cell activation in tumors." In its paper, team says that "miR-511-3p modulates genetic programs of tumor-associated macrophages," and identifies direct targets of the miRNA.